| Home Market Dynamics Sector Analysis Company Insights AI Investing Strategies Contact Us Login |
| Gilead Sciences is making significant strides in HIV drug development, with a focus on innovative therapies like lenacapavir, which offers the convenience of twice-yearly dosing. This advancement not only enhances patient adherence but also strengthens Gilead's competitive edge in the antiviral market. Furthermore, the successful approval of such breakthrough therapies is likely to boost investor confidence and solidify Gilead's reputation as a leader in infectious disease treatment. As the demand for effective HIV therapies continues to grow, Gilead is well-positioned to capitalize on this evolving landscape. |
| The price action of Gilead Sciences (GILD) is impacted by broad market risk appetite, sector price trend, company-specific performance and market structure. The market sentiment at 0.1 is modestly bullish. Trend sentiment measures the current trend of the stock price, and market sentiment reflects what market participants collectively think where the price will move next.There is no clear direction for GILD since trend sentiment and market sentiment are at the opposite directions. The positive sentiment force for sector is at 0.3, and the negative at -0.2 on 2025-10-02. The forces of and Valuation Sentiment (-1) will drive down the price. The forces of Stock Price Trend (0), Sector Price Trend (0), Price Level Sentiment (0), Option Sentiment (0), Market Risk Appetite (0), and Sentiment towards Fundamentals (1.5) will drive up the price. The sentiment for Sector Price Trend is calculated based on the price trend of related sector ETF. The sentiment for Option Speculation is calculated from put/call ratio. The Risk Appetite is calculated from Bitcoin price trend. Price Level sentiment is positive when oversold, and negative when overbought. Valuation Sentiment, and Sentimentals towards Fundamentals are extracted from headlines and market commentary. All sentiment scores are normalized on a -10 - +10 scale. The price level reaches 100 at Bollinger upper band, and zero at lower band. |
| GILD | |||||||||||||
| Date | Attention | Price | Price Level | Change | SMA10 Trend | Trend Sentiment | Hourly Trend | Hourly StdDev | Market Sentiment | Action | P | Fund. | News Sentiment |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025-10-02 | 0%(0%) | 0 | 0% | 0.1 | 1.5 | -1 | |||||||
| 2025-10-01 | 0%(0%) | 0 | 0% | 0.1 | 1.8 | -1 | |||||||
| 2025-09-30 | 0%(0%) | 0 | 0% | 0.3 | 2.6 | -1 | |||||||
| 2025-09-29 | 0%(0%) | 0 | 0% | 0.4 | 3.2 | -1 | |||||||
| 2025-09-28 | 0%(0%) | 0 | 0% | 0.4 | 3.6 | -1 | |||||||
| 2025-09-27 | 0%(0%) | 0 | 0% | 0.4 | 3.6 | -1 | |||||||
| 2025-09-26 | 0%(0%) | 0 | 0% | 0.4 | 3.6 | -1 | |||||||
| 2025-09-25 | 0%(0%) | 0 | 0% | 0.4 | 3.6 | -1 | |||||||
| 2025-09-24 | 0%(0%) | 0 | 0% | 0.4 | 3.1 | -1 | |||||||
| 2025-09-23 | 0%(0%) | 0 | 0% | 0.4 | 3.2 | -1 | |||||||
| Wait action is recommended in three scenarios with either high uncertainty or high risk: 1. The trend sentiment and market sentiment are at the opposite directions. 2. Both trend sentiment and market sentiment are positive, but the price level is elevated. 3. Both trend sentiment and market sentiment are negative, but the price level is depressed. In an uptrend, as an investor, you may want to wait for the pullback to open long position. In a downtrend, the price will likely rebound after huge decline. As an investor, you may want to wait for the rebound to exit long position. | |||||||||||||
| Market sentiment will accelerate the current trend when both trend sentiment and market sentiment are at the same direction. Market sentiment will generate volatility when it's at the opposite direction of the trend sentiment. News sentiment measures the daily emotion of the market. News sentiment may impact the daily price change while market sentiment is a more stable and consistent moving force. | |||||||||||||
| 2025-10-02 17:11:10 The heightened awareness among investors indicates Gilead's competitive position within the pharmaceutical market. |
| 2025-10-02 17:11:10 The discussion around Gilead includes predictions for its earnings performance, which plays a critical role in stock analysis. |
| 2025-10-02 17:11:10 Gilead's positioning in the healthcare sector reflects significant dynamics and developments within the industry. |
| 2025-10-02 17:11:10 Analysts see potential in Gilead's stock, indicating a positive outlook for investors considering Long-term investments. |
| 2025-10-02 17:11:10 The increasing attention on Gilead Sciences' stock highlights the current trends within the stock market and investor interest. |